Meet Philippe Lopes-Fernandes
Executive Vice President and Chief Business Office
“Breakthroughs happen when we collaborate with partners who share our commitment to science, patients and delivering impact. Partnering to us, means following the right science, combining our strengths with those of our partners, and using our unique capabilities to ensure medicines reach patients, faster. Our alliances are deeply personal and built for the long term. Together, we know we go further.”
Philippe joined Ipsen in 2020, bringing over 20 years of leadership in global business development and acquisitions, spearheading deals across Europe, North America, and Asia, with senior BD roles at Merck KGaA. He received his degree from the Institut Supérieur de Gestion (ISG), is a French External Trade advisor (Conseiller du Commerce Extérieur), and board member of several companies. Philippe is responsible for driving Ipsen’s external innovation strategy and strengthening alliances across its key therapeutic areas of oncology, neuroscience, and rare disease. Since joining, he has played an instrumental role in delivering high-impact partnerships and M&As, contributing to the addition of over 30 new assets to Ipsen’s pipeline since 2020 and helping to strengthen its global innovation network.
Learn more about Philippe Lopes-Fernandes
Naomi Binoche
Vice President, Head of Strategic Alliance Management, Global Partnering
Nick Gagnon
Vice President, Head of Late Stage Partnering
Jordan Gass
Vice President, Head of Oncology Global Partnering
Kristine Yu
Vice President, Head of Rare Disease Global Partnering
External Innovation Team
We accelerate the most promising science through external innovation – partnering with biotech and academia to access cutting-edge innovation – combined with our internal R&D expertise.
Anuradha Connor
Vice President, Head of Oncology External Innovation
Clément Gautier
Senior Director, Head of Neuroscience & Rare Disease External Innovation
Contact the partnering team
At Ipsen, entering partnerships is always personal. Our team is committed to success and has the expertise to deliver it. Contact us to see how together, we can accelerate innovation for patients.
David Jenkins
How we work with our partners to accelerate innovation.
Christelle Huguet
How we work with our partners to turn a molecule into a medicine.
Partnering events
Throughout the year, Ipsen holds numerous events for and with partners. Look through our upcoming events if you are interested in our work and in partnering with us and would like to meet our team. Coming soon
Pipeline
Our robust development pipeline, backed by our expertise and external innovation strategy, support patients’ health outcomes across Oncology, Rare Disease, and Neuroscience.